Cisplatin in addition to single-agent first-line chemotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC): efficacy results of a joint analysis of the multicentre, randomized phase 3 MILES-3 and MILES-4 studies

Morabito A.;Cavanna L.;Luciani A.;Maione P.;Bonanno L.;Piazza E.;Leo S.;Cinieri S.;Morgillo F.;Burgio M. A.;Ferrara D.;Cortinovis D.;Rosetti F.;Costanzo R.;Sandomenico C.;Daniele G.;Signoriello S.;Piccirillo M. C.;Gallo C.;Perrone F.;Gridelli C.

2017